Algernon Health Inc. (CSE:AGN)
Canada
· Delayed Price · Currency is CAD 0.0800
0.00 (0.00%)
Dec 5, 2025, 9:30 AM EST
Algernon Health Balance Sheet
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 0.09 | 0.6 | 0.13 | 1.41 | 2.41 | 6.12 | Upgrade
|
| Cash & Short-Term Investments | 0.09 | 0.6 | 0.13 | 1.41 | 2.41 | 6.12 | Upgrade
|
| Cash Growth | -85.53% | 376.63% | -91.12% | -41.58% | -60.61% | 2845.66% | Upgrade
|
| Other Receivables | 0.01 | 0.02 | 0.1 | 0.67 | 2.29 | 1.23 | Upgrade
|
| Receivables | 0.01 | 0.02 | 0.1 | 0.67 | 2.29 | 1.23 | Upgrade
|
| Prepaid Expenses | 0.13 | 0.13 | 0.12 | 0.75 | 0.2 | 0.39 | Upgrade
|
| Total Current Assets | 0.23 | 0.74 | 0.34 | 2.83 | 4.91 | 7.74 | Upgrade
|
| Other Intangible Assets | 4.21 | 3.18 | 3.8 | 5.26 | 5.17 | 5.03 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.03 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
| Total Assets | 4.88 | 3.94 | 4.19 | 8.14 | 10.14 | 12.82 | Upgrade
|
| Accounts Payable | 2.07 | 1.75 | 2.7 | 2.24 | 1.02 | 0.61 | Upgrade
|
| Accrued Expenses | 0.12 | 0.02 | 0.02 | 0.27 | 0 | - | Upgrade
|
| Total Current Liabilities | 2.87 | 1.78 | 2.72 | 2.52 | 1.02 | 0.61 | Upgrade
|
| Total Liabilities | 3.14 | 1.78 | 2.72 | 2.52 | 1.02 | 0.61 | Upgrade
|
| Common Stock | 30.17 | 29.56 | 28.15 | 27.12 | 25.85 | 21.34 | Upgrade
|
| Retained Earnings | -30.45 | -30.76 | -30.79 | -25.19 | -23.55 | -17.46 | Upgrade
|
| Comprehensive Income & Other | 2.02 | 3.37 | 4.12 | 3.7 | 6.81 | 8.34 | Upgrade
|
| Shareholders' Equity | 1.74 | 2.17 | 1.47 | 5.62 | 9.12 | 12.22 | Upgrade
|
| Total Liabilities & Equity | 4.88 | 3.94 | 4.19 | 8.14 | 10.14 | 12.82 | Upgrade
|
| Net Cash (Debt) | 0.09 | 0.6 | 0.13 | 1.41 | 2.41 | 6.12 | Upgrade
|
| Net Cash Growth | -85.53% | 376.63% | -91.12% | -41.58% | -60.61% | 2845.66% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.03 | 0.01 | 0.20 | 0.39 | 1.74 | Upgrade
|
| Filing Date Shares Outstanding | 34.26 | 27.3 | 19.51 | 9.54 | 6.7 | 5.7 | Upgrade
|
| Total Common Shares Outstanding | 34.26 | 27.3 | 15.78 | 9.43 | 6.7 | 5.53 | Upgrade
|
| Working Capital | -2.64 | -1.04 | -2.38 | 0.31 | 3.89 | 7.13 | Upgrade
|
| Book Value Per Share | 0.05 | 0.08 | 0.09 | 0.60 | 1.36 | 2.21 | Upgrade
|
| Tangible Book Value | -2.88 | -1.01 | -2.32 | 0.37 | 3.94 | 7.19 | Upgrade
|
| Tangible Book Value Per Share | -0.08 | -0.04 | -0.15 | 0.04 | 0.59 | 1.30 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.